DURECT

$2.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.35%) Today

+$0.20 (+8.89%) As of 11:09 AM UTC after-hours

Why Robinhood?

You can buy or sell DURECT and other stocks, options, and ETFs commission-free!

About DRRX

DURECT Corporation Common Stock, also called DURECT, is a biopharmaceutical company. It engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA. The listed name for DRRX is DURECT Corporation Common Stock.

CEO

James E. Brown

Employees

Headquarters

Cupertino, California

Founded

1998

Market Cap

453.03M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

896.75K

High Today

$2.25

Low Today

$2.15

Open Price

$2.21

Volume

883.20K

52 Week High

$2.96

52 Week Low

$0.9502

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

DRRX Earnings

-$0.05

-$0.01

$0.03

$0.07

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 3, After Hours